Skip to content
Home » \ First introduction in Kanto! / More accurate diagnosis is possible with the introduction of PSMA-PET for dia gnosis of prostate cancer!

\ First introduction in Kanto! / More accurate diagnosis is possible with the introduction of PSMA-PET for dia gnosis of prostate cancer!

Medical Corporation DIC Utsunomiya Central Clinic
\ First introduction in Kanto! / More accurate diagnosis is possible with the introduction of PSMA-PET for diagnosis of prostate cancer! ……
On April 1, 2024, the medical corporation DIC Utsunomiya Central Clinic (Yaita-cho, Utsunomiya City, Tochigi Prefecture/Director Toshihiko Sato) (https://ucc.or.jp/) announced the launch of a breakthrough in the diagnosis of prostate cancer. As an advancement, we announced the introduction of PSMA-PET testing. PSMA-PET testing has high sensitivity and specificity in detecting prostate cancer, allowing for more accurate diagnosis than traditional imaging tests. ■What is “PSMA-PET test”? PSMA is a protein called “prostate-specific membrane antigen” that exists on the surface of prostate cells. The number of PSMA increases in prostate cancer and metastatic cancer. By taking advantage of this specificity and injecting a drug that has a radioactive substance attached to a molecule that recognizes proteins, the substance will concentrate on prostate cancer, making it possible to detect even small cancers more precisely. This test is included in guidelines in Europe and America, and is attracting a lot of attention around the world.
[Image 1: https://prtimes.jp/i/36040/4/resize/d36040-4-7c377411d6781cfc1385-0.png&s3=36040-4-3d6f450c0ae7a2d5d1a21a14f3cc5539-456×153.png ]
■Advantages of “PSMA-PET examination” It enables early detection of prostate cancer recurrence, staging, and judgment of treatment effectiveness, contributing to the formulation of appropriate treatment policies. This expands treatment options for prostate cancer patients and allows them to choose a treatment approach that is tailored to each individual patient.
Medical corporation DIC Utsunomiya Central Clinic (https://ucc.or.jp/) aims to contribute to the diagnosis and treatment of prostate cancer patients by introducing PSMA-PET testing. We will continue to strive to advance technology and provide the highest standard of medical care to our patients.
[Image 2: https://prtimes.jp/i/36040/4/resize/d36040-4-1dbe6b307a39cb729020-1.jpg&s3=36040-4-35ba3ed183bbb47f892848f180cd5307-436×431.jpg]

More details about this release:
https://prtimes.jp/main/html/rd/p/000000004.000036040.html



%d